These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24303007)

  • 1. Beclin 1 deficiency correlated with lymph node metastasis, predicts a distinct outcome in intrahepatic and extrahepatic cholangiocarcinoma.
    Wang TT; Cao QH; Chen MY; Xia Q; Fan XJ; Ma XK; Lin Q; Jia CC; Dong M; Ruan DY; Lin ZX; Wen JY; Wei L; Li X; Chen ZH; Wang L; Wu XY; Wan XB
    PLoS One; 2013; 8(11):e80317. PubMed ID: 24303007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinoma.
    Dong LW; Hou YJ; Tan YX; Tang L; Pan YF; Wang M; Wang HY
    Autophagy; 2011 Oct; 7(10):1222-9. PubMed ID: 21654208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma.
    Wu DH; Jia CC; Chen J; Lin ZX; Ruan DY; Li X; Lin Q; Min-Dong ; Ma XK; Wan XB; Cheng N; Chen ZH; Xing YF; Wu XY; Wen JY
    Tumour Biol; 2014 Dec; 35(12):12225-33. PubMed ID: 25256671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study.
    Bi C; Liu M; Rong W; Wu F; Zhang Y; Lin S; Liu Y; Wu J; Wang L
    BMC Cancer; 2019 Mar; 19(1):213. PubMed ID: 30849962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
    Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
    Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
    Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma.
    Sha M; Jeong S; Wang X; Tong Y; Cao J; Sun HY; Xia L; Xu N; Xi ZF; Zhang JJ; Kong XN; Xia Q
    BMC Cancer; 2019 Mar; 19(1):208. PubMed ID: 30849953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome.
    Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F
    Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.
    de Jong MC; Nathan H; Sotiropoulos GC; Paul A; Alexandrescu S; Marques H; Pulitano C; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Bauer TW; Walters DM; Gamblin TC; Nguyen KT; Turley R; Popescu I; Hubert C; Meyer S; Schulick RD; Choti MA; Gigot JF; Mentha G; Pawlik TM
    J Clin Oncol; 2011 Aug; 29(23):3140-5. PubMed ID: 21730269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma.
    Wu SY; Yu MX; Li XG; Xu SF; Shen J; Sun Z; Zhou X; Chen XZ; Tu JC
    Asian Pac J Cancer Prev; 2014; 15(7):3299-304. PubMed ID: 24815486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
    Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY
    Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma.
    Zhang JW; Chu YM; Lan ZM; Tang XL; Chen YT; Wang CF; Che X
    World J Gastroenterol; 2015 Apr; 21(14):4255-60. PubMed ID: 25892876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Budding in Intrahepatic Cholangiocarcinoma: A Predictor of Postsurgery Outcomes.
    Tanaka M; Yamauchi N; Ushiku T; Shibahara J; Hayashi A; Misumi K; Yasunaga Y; Morikawa T; Kokudo T; Arita J; Sakamoto Y; Hasegawa K; Fukayama M
    Am J Surg Pathol; 2019 Sep; 43(9):1180-1190. PubMed ID: 31335353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beclin 1 is highly expressed in papillary thyroid carcinoma and correlates with lymph node metastasis.
    Li X; Xu H; Ma H
    Acta Chir Belg; 2013; 113(3):175-81. PubMed ID: 24941712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery.
    Adachi T; Eguchi S; Beppu T; Ueno S; Shiraishi M; Okuda K; Yamashita Y; Kondo K; Nanashima A; Ohta M; Takami Y; Noritomi T; Kitahara K; Fujioka H
    Ann Surg Oncol; 2015 Jul; 22(7):2269-78. PubMed ID: 25582737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.
    Wakizaka K; Yokoo H; Kamiyama T; Ohira M; Kato K; Fujii Y; Sugiyama K; Okada N; Ohata T; Nagatsu A; Shimada S; Orimo T; Kamachi H; Taketomi A
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1074-1080. PubMed ID: 30462849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
    J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.